Ervogastat
id:
ervogastat-195-13722081
title:
Ervogastat
text:
Ervogastat is an experimental small-molecule drug and selective diacylglycerol O-acyltransferase 2 inhibitor developed by Pfizer for non-alcoholic steatohepatitis. Its development was previously halted by the company but resumed in 2022.
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental small-molecule drug
original url:
https://en.wikipedia.org/wiki/Ervogastat
date created:
date modified:
2023-11-24T21:25:10Z
main entity:
{"identifier":"Q123530868","url":"https://www.wikidata.org/entity/Q123530868"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c4/Ervogastat.svg","width":890,"height":380}
fields total:
13
integrity:
15